| Active ingredients | Dosage form | Quantity of active ingredients | Shortage status | Availability | Reason | Last updated |
| aripiprazole | Tablet, uncoated | 30 mg | Resolved | Available | Manufacturing | 22/09/2025 |
| clopidogrel hydrogen sulfate | Tablet, film coated | 97.9 mg | Current | Unavailable | Unexpected increase in consumer demand | 22/09/2025 |
| clopidogrel hydrogen sulfate | Tablet, film coated | 97.9 mg | Resolved | Available | Unexpected increase in consumer demand | 22/09/2025 |
| quetiapine fumarate | Tablet, modified release | 345.39 mg | Current | Limited Availability | Manufacturing | 22/09/2025 |
| quetiapine fumarate | Tablet, modified release | 345.39 mg | Anticipated | Available | Manufacturing | 22/09/2025 |
| quetiapine fumarate | Tablet, modified release | 230.26 mg | Anticipated | Available | Manufacturing | 22/09/2025 |
| metformin hydrochloride | Tablet, film coated | 1000 mg | Current | Unavailable | Unexpected increase in consumer demand | 22/09/2025 |
| solifenacin succinate | Tablet, film coated | 5 mg | Current | Unavailable | Manufacturing | 22/09/2025 |
| naloxone hydrochloride dihydrate | Injection | 440 microgram | Resolved | Available | Unexpected increase in consumer demand | 22/09/2025 |
| nitrofurantoin | Capsule, hard | 100 mg | Current | Limited Availability | Manufacturing | 22/09/2025 |
| methylphenidate hydrochloride | Capsule, modified release | 20 mg | Current | Limited Availability | Manufacturing | 22/09/2025 |
| sertraline hydrochloride | Tablet, film coated | 55.96 mg | Anticipated | Available | Manufacturing | 19/09/2025 |
| risperidone | Tablet | 1 mg | Anticipated | Available | Unexpected increase in demand due to other sponsors unable to supply | 19/09/2025 |
| ceftazidime pentahydrate | Injection, powder for | 2.328 g | Anticipated | Available | Manufacturing | 19/09/2025 |
| bisoprolol fumarate | Tablet | 2.5 mg | Current | Limited Availability | Manufacturing | 19/09/2025 |
| bisoprolol fumarate | Tablet | 5 mg | Anticipated | Available | Manufacturing | 19/09/2025 |
| bisoprolol fumarate | Tablet | 10 mg | Anticipated | Available | Manufacturing | 19/09/2025 |
| pioglitazone hydrochloride | Tablet, uncoated | 16.53 mg | Resolved | Available | Manufacturing | 19/09/2025 |
| lamivudine | Tablet, film coated | 300 mg | Anticipated | Available | Manufacturing | 19/09/2025 |
| pramipexole dihydrochloride monohydrate | Tablet | .125 mg | Current | Unavailable | Manufacturing | 19/09/2025 |
| temozolomide | Capsule, hard | 5 mg | Anticipated | Available | Manufacturing | 19/09/2025 |
| atorvastatin calcium trihydrate | Tablet, film coated | 21.69 mg | Anticipated | Available | Manufacturing | 19/09/2025 |
| atorvastatin calcium trihydrate | Tablet, film coated | 43.38 mg | Anticipated | Available | Manufacturing | 19/09/2025 |
| montelukast sodium | Tablet, film coated | 10.4 mg | Resolved | Available | Manufacturing | 19/09/2025 |
| pramipexole dihydrochloride monohydrate | Tablet, modified release | .75 mg | Current | Limited Availability | Manufacturing | 19/09/2025 |
| pramipexole dihydrochloride monohydrate | Tablet, modified release | .375 mg | Anticipated | Available | Manufacturing | 19/09/2025 |
| pramipexole dihydrochloride monohydrate | Tablet, modified release | 1.5 mg | Current | Limited Availability | Manufacturing | 19/09/2025 |
| tranexamic acid | Tablet, film coated | 500 mg | Current | Unavailable | Manufacturing | 19/09/2025 |
| ambrisentan | Tablet, film coated | 5 mg | Anticipated | Available | Manufacturing | 19/09/2025 |
| montelukast sodium | Tablet, chewable | 5.2 mg | Current | Unavailable | Manufacturing | 19/09/2025 |
| spironolactone | Tablet, uncoated | 25 mg | Current | Limited Availability | Manufacturing | 19/09/2025 |
| naltrexone hydrochloride | Tablet, film coated | 50 mg | Anticipated | Available | Manufacturing | 19/09/2025 |
| furosemide | Injection, solution | 20 mg | Anticipated | Available | Manufacturing | 19/09/2025 |
| aripiprazole monohydrate | Injection, powder for | 416.07 mg | Current | Unavailable | Manufacturing | 19/09/2025 |
| lamotrigine | Tablet, chewable | 100 mg | Current | Unavailable | Manufacturing | 18/09/2025 |
| lamotrigine | Tablet, chewable | 200 mg | Current | Unavailable | Manufacturing | 18/09/2025 |
| sildenafil citrate | Tablet, film coated | 140.45 mg | Current | Limited Availability | Unexpected increase in demand due to other sponsors unable to supply | 18/09/2025 |
| ondansetron hydrochloride dihydrate | Tablet, film coated | 9.972 mg | Current | Limited Availability | Manufacturing | 18/09/2025 |
| metronidazole | Tablet, uncoated | 400 mg | Current | Limited Availability | Manufacturing | 18/09/2025 |
| atorvastatin calcium trihydrate | Tablet, film coated | 21.69 mg | Current | Unavailable | Manufacturing | 18/09/2025 |
| atorvastatin calcium trihydrate | Tablet, film coated | 43.38 mg | Anticipated | Available | Manufacturing | 18/09/2025 |
| galantamine hydrobromide | Capsule, modified release | 20.504 mg | Current | Unavailable | Manufacturing | 18/09/2025 |
| indapamide hemihydrate | Tablet, sugar coated | 2.5 mg | Anticipated | Available | Manufacturing | 18/09/2025 |
| montelukast sodium | Tablet, chewable | 5.2 mg | Resolved | Available | Manufacturing | 18/09/2025 |
| montelukast sodium | Tablet, chewable | 5.2 mg | Current | Unavailable | Unexpected increase in consumer demand | 18/09/2025 |
| montelukast sodium | Tablet, chewable | 4.16 mg | Current | Unavailable | Manufacturing | 18/09/2025 |
| ciprofloxacin hydrochloride | Tablet, film coated | 277.5 mg | Resolved | Available | Manufacturing | 18/09/2025 |
| ciprofloxacin hydrochloride | Tablet, film coated | 555 mg | Resolved | Available | Manufacturing | 18/09/2025 |
| ciprofloxacin hydrochloride | Tablet, film coated | 832.5 mg | Resolved | Available | Manufacturing | 18/09/2025 |
| ropivacaine hydrochloride | Injection, solution | 40 mg | Resolved | Available | Transport / Logistic issues / Storage capacity issues | 18/09/2025 |
| ropivacaine hydrochloride | Injection, solution | 150 mg | Resolved | Available | Transport / Logistic issues / Storage capacity issues | 18/09/2025 |
| risperidone | Tablet, film coated | .5 mg | Current | Unavailable | Manufacturing | 18/09/2025 |
| amlodipine besilate~atorvastatin calcium trihydrate | Tablet, film coated | 6.94 mg~43.376 mg | Current | Unavailable | Manufacturing | 18/09/2025 |
| amlodipine besilate~atorvastatin calcium trihydrate | Tablet, film coated | 13.88 mg~10.844 mg | Current | Unavailable | Manufacturing | 18/09/2025 |
| amlodipine besilate~atorvastatin calcium trihydrate | Tablet, film coated | 13.88 mg~43.376 mg | Current | Limited Availability | Manufacturing | 18/09/2025 |
| citalopram hydrobromide | Tablet, film coated | 12.495 mg | Current | Unavailable | Manufacturing | 18/09/2025 |
| citalopram hydrobromide | Tablet, film coated | 49.98 mg | Current | Unavailable | Manufacturing | 18/09/2025 |
| nizatidine | Capsule, hard | 150 mg | Current | Unavailable | Manufacturing | 18/09/2025 |
| ivabradine hydrochloride | Tablet, film coated | 8.085 mg | Current | Unavailable | Manufacturing | 18/09/2025 |
| bimatoprost | Eye Drops | .3 mg/mL | Anticipated | Available | Manufacturing | 18/09/2025 |
| eplerenone | Tablet, film coated | 25 mg | Anticipated | Available | Manufacturing | 18/09/2025 |
| lacosamide | Tablet, film coated | 50 mg | Anticipated | Available | Manufacturing | 18/09/2025 |
| risperidone | Oral Liquid, solution | 1 mg/mL | Current | Unavailable | Manufacturing | 18/09/2025 |
| montelukast sodium | Tablet, chewable | 5.2 mg | Resolved | Available | Manufacturing | 18/09/2025 |
| lamotrigine | Tablet, chewable | 50 mg | Anticipated | Available | Manufacturing | 18/09/2025 |
| lamotrigine | Tablet, chewable | 100 mg | Anticipated | Available | Manufacturing | 18/09/2025 |
| lamotrigine | Tablet, chewable | 200 mg | Current | Unavailable | Manufacturing | 18/09/2025 |
| rivaroxaban | Tablet, film coated | 10 mg | Anticipated | Available | Manufacturing | 18/09/2025 |
| rivaroxaban | Tablet, film coated | 10 mg | Anticipated | Available | Manufacturing | 18/09/2025 |
| dosulepin hydrochloride | Tablet, film coated | 75 mg | Anticipated | Available | Manufacturing | 18/09/2025 |
| minocycline hydrochloride dihydrate | Tablet, film coated | 54 mg | Current | Limited Availability | Manufacturing | 18/09/2025 |
| ciprofloxacin hydrochloride | Tablet, film coated | 873.32 mg | Anticipated | Available | Manufacturing | 18/09/2025 |
| betamethasone valerate | Cream | 1.21 mg/g | Current | Limited Availability | Manufacturing | 17/09/2025 |
| bromocriptine mesilate | Tablet, uncoated | 2.87 mg | Current | Unavailable | Manufacturing | 17/09/2025 |
| fentanyl | Drug delivery system, transdermal | 16.8 mg | Resolved | Available | Unexpected increase in demand due to other sponsors unable to supply | 17/09/2025 |
| mycophenolate mofetil | Tablet, film coated | 500 mg | Current | Limited Availability | Manufacturing | 17/09/2025 |
| entacapone~carbidopa monohydrate~levodopa | Tablet, film coated | 200 mg~13.5 mg~50 mg | Current | Limited Availability | Manufacturing | 17/09/2025 |
| midazolam | Injection, solution | 50 mg | Anticipated | Available | Manufacturing | 17/09/2025 |
| hydromorphone hydrochloride | Injection, solution | 2 mg/mL | Discontinued | Unavailable | Commercial Changes / Commercial viability | 17/09/2025 |
| rifampicin | Capsule, hard | 150 mg | Current | Limited Availability | Manufacturing | 17/09/2025 |
| rifampicin | Capsule, hard | 300 mg | Current | Unavailable | Manufacturing | 17/09/2025 |
| methylphenidate hydrochloride | Capsule, modified release | 40 mg | Current | Limited Availability | Manufacturing | 17/09/2025 |
| Epoetin beta | Injection | 16666.67 IU/mL | Discontinued | Reduction in supply until supply is exhausted | Transport / Logistic issues / Storage capacity issues | 16/09/2025 |
| lidocaine hydrochloride | Injection, solution | 20 mg/mL | Current | Unavailable | Manufacturing | 16/09/2025 |
| tetrabenazine | Tablet, uncoated | 25 mg | Current | Unavailable | Manufacturing | 16/09/2025 |
| montelukast sodium | Tablet, chewable | 5.2 mg | Current | Unavailable | Manufacturing | 16/09/2025 |
| phenoxymethylpenicillin potassium | Tablet, film coated | 560 mg | Current | Limited Availability | Manufacturing | 16/09/2025 |
| fluticasone propionate | Inhalation, powder for | 20 mg/g | Current | Limited Availability | Manufacturing | 16/09/2025 |
| cidofovir | Injection, concentrated | 75 mg/mL | Current | Limited Availability | Manufacturing | 16/09/2025 |
| levodopa~carbidopa monohydrate | Tablet, uncoated | 100 mg~27 mg | Current | Limited Availability | Manufacturing | 16/09/2025 |
| aciclovir | Eye Ointment | .135 g | Resolved | Available | Manufacturing | 16/09/2025 |
| ropivacaine hydrochloride | Injection, solution | 7.5 mg/mL | Current | Limited Availability | Manufacturing | 16/09/2025 |
| ropivacaine hydrochloride | Injection, solution | 7.5 mg/mL | Current | Unavailable | Manufacturing | 16/09/2025 |
| norethisterone~ethinylestradiol | Tablet, uncoated | 500 microgram~36 microgram | Anticipated | Available | Manufacturing | 16/09/2025 |
| mesalazine | Suppository, compressed | 1000 mg | Current | Limited Availability | Transport / Logistic issues / Storage capacity issues | 16/09/2025 |
| primidone | Tablet, uncoated | 250 mg | Anticipated | Available | Manufacturing | 15/09/2025 |
| lidocaine hydrochloride~adrenaline (epinephrine) acid tartrate | Injection, solution | 20 mg/mL~9.1 microgram/mL | Current | Unavailable | Manufacturing | 15/09/2025 |
| benzathine benzylpenicillin tetrahydrate | Injection, suspension | 1200000 USP Unit | Current | Limited Availability | Manufacturing | 15/09/2025 |
| pramipexole dihydrochloride monohydrate | Tablet | 1 mg | Resolved | Available | Manufacturing | 15/09/2025 |
| valsartan~hydrochlorothiazide | Tablet, film coated | 160 mg~12.5 mg | Resolved | Available | Manufacturing | 15/09/2025 |
| ropivacaine hydrochloride | Injection, solution | 200 mg | Current | Unavailable | Transport / Logistic issues / Storage capacity issues | 15/09/2025 |
| quetiapine fumarate | Tablet, modified release | 57.565 mg | Resolved | Available | Unexpected increase in consumer demand | 15/09/2025 |
| salmeterol xinafoate~fluticasone propionate | Inhalation, pressurised | 36.3 microgram/actuation~125 microgram/actuation | Current | Limited Availability | Unexpected increase in consumer demand | 15/09/2025 |
| entecavir | Tablet, film coated | 1 mg | Anticipated | Available | Manufacturing | 15/09/2025 |
| tadalafil | Tablet, film coated | 5 mg | Discontinued | Reduction in supply until supply is exhausted | Commercial Changes / Commercial viability | 15/09/2025 |
| hydrocortisone | Tablet, uncoated | 4 mg | Resolved | Available | Manufacturing | 15/09/2025 |
| benzathine benzylpenicillin tetrahydrate | Injection, suspension | 600000 USP Unit | Current | Unavailable | Manufacturing | 15/09/2025 |
| metronidazole | Injection, solution | 500 mg | Resolved | Available | Transport / Logistic issues / Storage capacity issues | 15/09/2025 |
| methylphenidate hydrochloride | Tablet, modified release | 18 mg | Resolved | Available | Unexpected increase in demand due to other sponsors unable to supply | 15/09/2025 |
| lorazepam | Tablet | 1 mg | Resolved | Available | Manufacturing | 15/09/2025 |
| carboplatin | Injection, solution | 10 mg/mL | Current | Unavailable | Unexpected increase in demand due to other sponsors unable to supply | 15/09/2025 |
| framycetin sulfate | Eye and Ear Drops | 5 mg/mL | Resolved | Available | Transport / Logistic issues / Storage capacity issues | 15/09/2025 |
| nizatidine | Capsule | 150 mg | Resolved | Available | Manufacturing | 15/09/2025 |
2025年9月22日